Seres Therapeutics: 3Q Earnings Snapshot

November 8, 2018

CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Thursday reported a loss of $21.9 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 54 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The drug developer posted revenue of $9.1 million in the period.

Seres Therapeutics shares have decreased 20 percent since the beginning of the year. The stock has decreased 16 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB

Update hourly